Hidradenitis suppurativa – Management, comorbidities and monitoring

Hidradenitis suppurativa Research


Author(s): Vekic DA, Cains GD

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disease presenting in intertriginous areas. HS is associated with a number of disease-modifying comorbidities, including metabolic syndrome and androgen dysfunction, and smoking.

OBJECTIVE: This review provides a synopsis of the aetiology and diagnosis of HS, and an overview of management for this often devastating disease.

DISCUSSION: The clinical course and disease severity of HS are variable among patients. HS has profound physical and psychological consequences that affect patients’ quality of life. Effective treatment is now a realistic goal, but needs to be combined with treatment of the comorbidities and psyche. Evidence-based management guidelines have been established for the management of this disease. General practitioners play a pivotal role in the holistic treatment of this disease.


Dermatology Journal and/or Publisher

Journal Name: Australian family physician
Journal Abbreviation: Aust Fam Physician
Journal Date Published: 2017-08-08


National Center for Biotechnology Information

PMID: 28787558
Article Source: http://www.ncbi.nlm.nih.gov/pubmed/28787558
Lasted Revision: 2017-08-08


Abstract Source: National Center for Biotechnology Information, U.S. National Library of Medicine Abstract Query for Hidradenitis suppurativa (HS).


0 Comments

Leave a reply

HSAWARENESS.ORG | Fighting for Hidradenitis suppurativa (HS), a.k.a Acne Inversa Patient and Doctor Awareness ©2017 hidradenitissuppurativaawareness.org  All Rights Reserved. Your use of this website constitutes explicit agreement to our Terms of Use and Privacy Policies. This website does not provide medical advice, diagnosis or treatment.

Log in with your credentials

Forgot your details?